Tuberculosis (TB) continues to pose a significant global health challenge, with timely and accurate diagnosis remaining critical for effective disease control. Recent developments in diagnostic tools—including rapid molecular testing, gene-based assays, and imaging technologies—have improved detection speed and sensitivity, particularly in drug-resistant cases. Early identification of TB not only facilitates prompt treatment but also reduces transmission and mitigates long-term complications.